| 000 | 01725 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517165521.0 | ||
| 264 | 0 | _c20180517 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1399-3003 | ||
| 024 | 7 |
_a10.1183/13993003.02337-2016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, Xinping | |
| 245 | 0 | 0 |
_aOestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects. _h[electronic resource] |
| 260 |
_bThe European respiratory journal _c08 2017 |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnastrozole |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBone Morphogenetic Protein Receptors, Type II _xgenetics |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aEchocardiography |
| 650 | 0 | 4 |
_aEstradiol _xanalogs & derivatives |
| 650 | 0 | 4 |
_aEstrogen Antagonists _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFulvestrant |
| 650 | 0 | 4 | _aHemodynamics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 |
_aLung _xpathology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNitriles _xpharmacology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aTamoxifen _xpharmacology |
| 650 | 0 | 4 |
_aTriazoles _xpharmacology |
| 700 | 1 | _aAustin, Eric D | |
| 700 | 1 | _aTalati, Megha | |
| 700 | 1 | _aFessel, Joshua P | |
| 700 | 1 | _aFarber-Eger, Eric H | |
| 700 | 1 | _aBrittain, Evan L | |
| 700 | 1 | _aHemnes, Anna R | |
| 700 | 1 | _aLoyd, James E | |
| 700 | 1 | _aWest, James | |
| 773 | 0 |
_tThe European respiratory journal _gvol. 50 _gno. 2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1183/13993003.02337-2016 _zAvailable from publisher's website |
| 999 |
_c27433158 _d27433158 |
||